Alex Zhavoronkov’s Post

Many of you know Aubrey de Grey, but few are aware of the magnitude of his new RMR project and its impact. They are testing multiple therapeutic interventions in mice for effects on longevity. Stay tuned for a quick overview in 5 minutes or less from Founders Forum Group Longevity Forum during the London Tech Week.

Graham Ewing

Director at QueMaco Limited; Director, Mimex Healthcare (UK) Limited Former CEO, Mimex Montague Healthcare Limited

1w

The idea of developing a drug which can slow the aging process is complete and utter nonsense. All drugs are toxic substances so the idea that you can administer a toxic substance and enhance your longevity does not make sense. Moreover, which pathological process is the anti-aging drug going to target in order to enhance longevity. Let me repeat - this is complete, utter, nonsense. The body is neurally regulated entity which modulates the function of the body’s functional systems. All medical conditions without exception are multipathological. Each pathology comprises a genetic component and a lifestyle component so let me ask again which particular process is the life enhancing drug going to target? The only viable way to stand a chance of enhancing longevity is by understanding and adapting the brain’s natural neuromodulatory effect upon the body.

Like
Reply

Research on extending lifespan is complex and multidisciplinary. An integrative approach combining pharmacological, genetic, and neuromodulatory methods holds promising results. Aubrey de Grey’s RMR project is a significant step in this direction and should be pursued to better understand and utilize its potential.

Like
Reply
Graham Ewing

Director at QueMaco Limited; Director, Mimex Healthcare (UK) Limited Former CEO, Mimex Montague Healthcare Limited

1w

Enrique Segarra Read my paper. I cited it in my earlier response. Moreover please note that I base my comments upon a fully developed technology which you can view by googling Mediabox+Strannik Moreover if you disagree I will be pleased to accept your challenge: your technology, your drugs versus Strannik

Like
Reply
Orest Blaschuk

Founder and President at Zonula Incorporated (Therapeutics targeting cell adhesion)

1w

Very informative interview. Interesting new (for me) term: medical tourism. I would envision the emergence of cities dedicated to seniors.

Like
Reply
Victor Björk

Business Development Professional | Longevity Biotech

1w

Nice!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics